TRIMU-5 is a selective agonist of the μ₂-opioid receptor and antagonist of the μ₁-opioid receptor. It produces

analgesia Pain management is an aspect of medicine and health care involving relief of pain (pain relief, analgesia, pain control) in various dimensions, from acute and simple to chronic and challenging. Most physicians and other health professional ...

in animals that differs from that of conventional

μ-opioid receptor The μ-opioid receptors (MOR) are a class of opioid receptors with a high affinity for enkephalins and beta-endorphin, but a low affinity for dynorphins. They are also referred to as μ(''mu'')-opioid peptide (MOP) receptors. The prototypical � ...

agonists but that can still be blocked by μ-opioid receptor antagonists. TRIMU-5 can also block the analgesic effects of μ-opioid receptor agonists like

morphine Morphine is a strong opiate that is found naturally in opium, a dark brown resin in poppies (''Papaver somniferum''). It is mainly used as a pain medication, and is also commonly used recreationally, or to make other illicit opioids. T ...

. In addition to analgesia, TRIMU-5 inhibits gastrointestinal transit, a known effect of μ₂-opioid receptor activation.

References

Mu-opioid receptor agonists Opioid peptides {{Analgesic-stub